isothiocyanic acid has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graf, BL; Jaja-Chimedza, A; Kim, Y; Kuhn, P; Pauli, GF; Raskin, I; Simmler, C | 1 |
| Fimognari, C; Milelli, A; Minarini, A; Simoni, E; Tumiatti, V; Turrini, E | 1 |
| Carino, A; Cipriani, S; D'Amore, C; De Tursi, AA; Fiorucci, S; Monti, MC; Renga, B; Sepe, V; Simonetti, M; Zampella, A | 1 |
| Han, SH; Hwang, O; Kim, DJ; Kim, HR; Kim, JH; Lee, JA; Park, KD; Shin, N; Son, HJ | 1 |
| Imai, Y; Kobayashi, C; Kurohane, K | 1 |
| Egashira, Y; Hara, H; Iwama, T; Ono, Y; Sawada, S; Shimazawa, M; Takagi, T; Tsuruma, K | 1 |
| Chikaraishi, Y; Hara, H; Shimazawa, M; Yokota, K; Yoshino, K | 1 |
| Adam-Rodwell, G; Morse, MA; Stoner, GD | 1 |
| Gebhard, MM; Herfarth, C; Klar, E; Schmidt, J; Warshaw, AL; Werner, J | 1 |
1 review(s) available for isothiocyanic acid and Disease Models, Animal
| Article | Year |
|---|---|
Exploring the effects of isothiocyanates on chemotherapeutic drugs.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoprevention; Diet; Disease Models, Animal; Drug Evaluation, Preclinical; Food-Drug Interactions; Humans; Isothiocyanates; Neoplasms; Randomized Controlled Trials as Topic | 2014 |
8 other study(ies) available for isothiocyanic acid and Disease Models, Animal
| Article | Year |
|---|---|
Biochemical characterization and anti-inflammatory properties of an isothiocyanate-enriched moringa (Moringa oleifera) seed extract.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carrageenan; Cell Line; Curcuma; Curcumin; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Hindlimb; Inflammation; Isothiocyanates; Macrophages; Male; Moringa oleifera; Phytochemicals; Phytotherapy; Plant Extracts; Random Allocation; Rats, Sprague-Dawley; Seeds | 2017 |
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholanes; Cholestasis; Disease Models, Animal; Estrogens; Gene Deletion; Isothiocyanates; Ligands; Male; Mice; Pruritus; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |
A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Topics: Animals; Antioxidants; Cells, Cultured; Disease Models, Animal; Dopaminergic Neurons; Heme Oxygenase-1; Inflammation Mediators; Isothiocyanates; Male; Membrane Proteins; Mice, Inbred C57BL; Microglia; Motor Activity; NAD(P)H Dehydrogenase (Quinone); Neuroprotective Agents; NF-E2-Related Factor 2; Nuclear Proteins; Parkinson Disease; Signal Transduction | 2015 |
Lack of Impact of High Dietary Vitamin A on T Helper 2-Dependent Contact Hypersensitivity to Fluorescein Isothiocyanate in Mice.
Topics: Animals; Dermatitis, Contact; Diet; Dietary Supplements; Disease Models, Animal; Diterpenes; Fluorescein; Fluorescein-5-isothiocyanate; Isothiocyanates; Liver; Mice, Inbred BALB C; Pyridoxine; Retinyl Esters; Severity of Illness Index; Th1-Th2 Balance; Th2 Cells; Vitamin A | 2015 |
In Models of Intracerebral Hemorrhage, Rivaroxaban is Superior to Warfarin to Limit Blood Brain Barrier Disruption and Hematoma Expansion.
Topics: Animals; Anticoagulants; Blood-Brain Barrier; Cells, Cultured; Cerebral Hemorrhage; Disease Models, Animal; Electric Impedance; Endothelial Cells; Factor Xa Inhibitors; Hematoma; Isothiocyanates; Mice; Neurologic Examination; Permeability; Rivaroxaban; Treatment Outcome; Warfarin | 2017 |
CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Ischemia; Isothiocyanates; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Sulfones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2009 |
Lung tumors in strain A mice: application for studies in cancer chemoprevention.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Disease Models, Animal; DNA; DNA Damage; Drug Screening Assays, Antitumor; Female; Isothiocyanates; Lung Neoplasms; Male; Methylation; Mice | 1993 |
The relative safety of MRI contrast agent in acute necrotizing pancreatitis.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Monitoring; Erythrocytes; Gadolinium DTPA; Hemodynamics; Isothiocyanates; Magnetic Resonance Imaging; Male; Microcirculation; Pancreatitis, Acute Necrotizing; Rats; Rats, Wistar; Severity of Illness Index; Tomography, X-Ray Computed | 1998 |